Pharmacy Times®
Specialty Pharmacy Times
Aspirin Improves Survival in Colon Cancer Patients with Specific Tumor Type
Davy James, Associate Editor
Study finds aspirin improves survival outcomes only for patients with HLA class I antigen expression.
Armada Health Care Launches New Web Application Solution for Specialty Pharmacies
Study Finds Better Management of Specialty Drugs Could Provide Savings
Davy James, Associate Editor
CVS Caremark report projects that transition of specialty drugs from the medical benefit to the pharmacy benefit could provide significant cost relief to payers.
Immunosuppressive Drugs Affect Vaccine Response in Inflammatory Bowel Disease Patients
Eileen Oldfield, Associate Editor
Inflammatory bowel disease patients receiving immunosuppressive therapy had decreased immunogenicity to at least 1 of the 3 strains in the trivalent flu vaccine.
Kcentra by CSL Behring
Sylvester O. Agbahiwe, PharmD, BCACP, and Chika Obi, PharmD Candidate
Kcentra is the first nonactivated 4-factor prothrombin complex concentrate for the urgent reversal of acquired coagulation deficiency induced by vitamin K antagonist therapy.
Lymphoseek by Navidea Biopharmaceuticals
Michael R. Page, PharmD, RPh
In March 2013, the FDA approved Lymphoseek by Navidea Biopharmaceuticals. The medication acts as a diagnostic tool that helps surgeons identify and remove lymph nodes draining a tumor site.
Featured Video
Promoting Patient Adherence
Suzanne Tschida, PharmD, BCPS, vice president of specialty benefit and outcomes strategy at OptumRx, talks about promoting patient adherence.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 5
Number: 2
Conference Calendar
â—„        April 2014        â–º
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.